Net Cash Provided by (Used in) Operating Activities |
-1.07 M |
USD |
-25.4% |
Mar 31, 2024 |
2023 |
Net Cash Provided by (Used in) Financing Activities |
-6.49 M |
USD |
-1558% |
Mar 31, 2024 |
2023 |
Net Cash Provided by (Used in) Investing Activities |
7.58 M |
USD |
|
Mar 31, 2024 |
2023 |
Common Stock, Shares Authorized |
15 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
1.85 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
30.8 K |
USD |
+186% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
372 K |
USD |
+68.1% |
Mar 31, 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Jun 30, 2023 |
Q2 2023 |
Deferred Tax Assets, Gross |
321 K |
USD |
+85.3% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
2.98 K |
USD |
-93.8% |
Mar 31, 2024 |
2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
80.1 K |
USD |
|
Sep 30, 2022 |
Q3 2022 |
Deferred Federal Income Tax Expense (Benefit) |
2.98 K |
USD |
-93.8% |
Mar 31, 2024 |
2023 |
Unrecognized Tax Benefits |
0 |
USD |
-100% |
Mar 31, 2023 |
Q1 2023 |
Additional Paid in Capital |
795 K |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Current Federal Tax Expense (Benefit) |
613 K |
USD |
+142% |
Mar 31, 2024 |
2023 |
Deferred Tax Assets, Net of Valuation Allowance |
80.1 K |
USD |
|
Sep 30, 2022 |
Q3 2022 |